Pharmafile Logo
Pharmafocus logo
Advanced Search

no-deal Brexit

Showing 3 posts of 3 posts found.

Royal Pharmaceutical Society in Scotland says contingency plans do not mitigate risk of no-deal Brexit

July 19, 2019
Medical Communications RPS, brexit, no-deal Brexit, pharma, pharmaceuticals

The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks …

News
28246711066_52e38bc591_z

Healthcare industry could take up to five years to stabilise after no-deal Brexit

March 13, 2019
Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …

News
28246711066_52e38bc591_z

Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit

October 24, 2018
Research and Development brexit, no-deal Brexit, stockpiling

Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026